Abstract:Background: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is considered to result from the interaction of environmental factors, including intestinal microbiota, with host immune mechanisms in genetically susceptible individuals. Association studies in human and mice indicate that no single organisms are causal for IBD, but instead reflect a broad dysbiosis, suggesting that distinct organisms sharing similar traits may be operative. Owing to the complexity and low inter-individual overlap of the intestinal microbiota, no biologically and ecologically integrated microbial signature of this dysbiosis has been identified in IBD. Results: We performed a study of endoscopic lavage samples from different anatomical sites in 64 subjects (32 normal (NM), 16 CD and 16 UC patients in remission). The V4 region of the 16S ribosomal RNA gene of 190 total mucosal lavage samples was sequenced on an Illumina HiSeq 2000. The microbial composition of lavage specimens was more similar to mucosal biopsies versus fecal compartment (phylum-level Pearson similarity analysis with published datasets), suggesting that mucosal lavage sampling is a good reflection of mucosal-associated microbiota. Phylogenetic diversity was reduced in IBD patients compared to NM subjects. While expected from prior studies of active disease, this is the first demonstration that such differences persist in clinically quiescent phases of disease. A subset of IBD-enriched microbial communities was identified by PCoA of the unweighted UniFrac distance matrix. Network-based analysis of microbial co-occurrence patterns identified 8 functional microbial communities (FMCs). Only one FMC was related to any of the previously reported fecal enterotypes. Bioinformatic validation with two independent mucosal (biopsy) datasets showed that these FMCs are a significantly preserved characteristic of the mucosal surface ecology. Two FMCs were positively and negatively associated with IBD phenotype, and with ATG16L1 and NOD2 risk alleles. Conclusions: We have introduced mucosal lavage as a new sampling method to study host-microbial interaction, and module analysis to identify integrated mucosal ecology parameters for microbial community structure. Our results demonstrate the feasibility of detecting subtle variation between NM and IBD microbiota using relatively short Illumina reads. The identification of FMCs indicated that the intestinal microbiota can be defined as a set of reproducible microbial communities, and that a subset of these are selectively augmented or depleted in IBD patient samples, and with related disease-associated genotypes. Such disease-associated communities provide a new tool to define disease states as microbial ecologic units, and potentially novel integrated units to monitor deleterious microbial states and for therapeutic targeting.

Noninvasive, microbiome-based diagnosis of inflammatory bowel disease

Systematic Mining of gut microbiota biomarkers for IBD

Microbiome and Metabolome Features in Inflammatory Bowel Disease Via Multi-Omics Integration Analyses Across Cohorts

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease

Gut Microbiota Offers Universal Biomarkers Across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction

Diagnosis of Crohn's disease and ulcerative colitis using the microbiome

The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease

P380 Integrated fecal metagenome and serum metabolome analysis revealed gut microbiome associated serum metabolites as diagnostic biomarkers for inflammatory bowel disease

Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease

The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease

Gut microbiome structure and metabolic activity in inflammatory bowel disease

Su1930 Nuclear Nano-Morphology Markers from Rectal Tissue for the Surveillance of Colorectal Cancer in Patients with Ulcerative Colitis

ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?

Integrating Gut Microbiota and Host Immune Markers for Highly Accurate Diagnosis of Clostridioides Difficile Infection

Establishing a Novel Inflammatory Bowel Disease Prediction Model Based on Gene Markers Identified from Single Nucleotide Variants of the Intestinal Microbiota

Dysbiosis and Ecotypes of the Salivary Microbiome Associated with Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.

Molecular diagnosis and classification of inflammatory bowel disease

Microbial and Genetic-Based Framework Identifies Drug Targets in Inflammatory Bowel Disease.

A Novel Tool For Noninvasive Diagnosis And Tracking Of Patients With Inflammatory Bowel Disease

P070 Machine learning approaches to identify IBD biomarkers from longitudinal microbiome data